What is Zacks Research’s Forecast for IRWD Q2 Earnings?

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Analysts at Zacks Research upped their Q2 2025 EPS estimates for Ironwood Pharmaceuticals in a report issued on Thursday, May 1st. Zacks Research analyst R. Department now forecasts that the biotechnology company will post earnings per share of $0.03 for the quarter, up from their prior estimate […]

Leave a Reply

Your email address will not be published.

Previous post What is DA Davidson’s Forecast for Kadant Q2 Earnings?
Next post Promising Green Energy Stocks To Follow Today – May 3rd